Science Explorer Interactive view Map
Company · Cambridge · United Kingdom

AstraZeneca (United Kingdom)

In research, AstraZeneca (United Kingdom) stands highest in Life Sciences (#995 of 7,800 worldwide), Medicine (#1,468 of 10,443 worldwide) and Health Sciences (#1,988 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Immunology — Oncology is 8.5× its share of world research.

astrazeneca.comROR OpenAlex
World rank, 2022–2025
#1,949
of 28,054 · #1,387 all time
Rank in United Kingdom
#79
of 1,094
Research works
7.3k
◆ 1% vs 2013–17
Citations
294k
40.5 per fractional work
Top-10% rate
22.6%
record average 16.5%
Open access
32%
world 28%

What is AstraZeneca (United Kingdom) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #995 of 7,800 25.5%221 #761
MedicineField #1,468 of 10,443 21.0%396 #844
Health SciencesDomain #1,988 of 11,982 20.9%411 #1073
Biochemistry, Genetics and Molecular BiologyField #974 of 3,579 27.1%156 #550
Physical SciencesDomain #3,634 of 12,888 24.2%158 #2049
Pulmonary and Respiratory MedicineSubfield #379 of 1,144 20.2%89 #400
Molecular BiologySubfield #931 of 2,175 26.7%107 #490
OncologySubfield #357 of 772 24.7%79 #237

Each strip is that field’s whole ranked pool, with the notch where AstraZeneca (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Life Sciences#761 #995
  2. Medicine#844 #1,468
  3. Health Sciences#1,073 #1,988
  4. Biochemistry, Genetics and Molecular Biology#550 #974
  5. Physical Sciences#2,049 #3,634
  6. Pulmonary and Respiratory Medicine#400 #379
  7. Molecular Biology#490 #931
  8. Oncology#237 #357
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does AstraZeneca (United Kingdom) specialise in?

Where its research is concentrated relative to its size: Oncology takes 8.5× the share of its output that it takes of world research.

  1. OncologySubfield · 78.9 works8.5×
  2. Pulmonary and Respiratory MedicineSubfield · 89.2 works7.0×
  3. ImmunologySubfield · 37.6 works6.6×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 4 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.55× its world share, 156 worksBiochemistry, Geneti…Immunology and Microbiology: 4.66× its world share, 39 worksImmunology and Micro…Neuroscience: 0.65× its world share, 9 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.89× its world share, 14 worksPharmacology, Toxico…Chemical Engineering: 0.86× its world share, 2 worksChemical EngineeringChemistry: 3.92× its world share, 51 worksChemistryComputer Science: 0.37× its world share, 24 worksComputer ScienceEarth and Planetary Sciences: 0.04× its world share, 1 worksEarth and Planetary …Energy: 0.11× its world share, 1 worksEnergyEngineering: 0.23× its world share, 28 worksEngineeringEnvironmental Science: 0.39× its world share, 16 worksEnvironmental ScienceMaterials Science: 0.57× its world share, 16 worksMaterials ScienceMathematics: 1.58× its world share, 15 worksMathematicsPhysics and Astronomy: 0.20× its world share, 4 worksPhysics and AstronomyDentistry: 0.01× its world share, 0 worksDentistryHealth Professions: 0.55× its world share, 12 worksHealth ProfessionsMedicine: 2.50× its world share, 396 worksMedicineNursing: 0.14× its world share, 1 worksNursingVeterinary: 1.92× its world share, 2 worksVeterinaryArts and Humanities: 0.01× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.60× its world share, 5 worksDecision SciencesEconomics, Econometrics and Finance: 1.33× its world share, 24 worksEconomics, Econometr…Psychology: 0.05× its world share, 1 worksPsychologySocial Sciences: 0.05× its world share, 5 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.9×. Every wedge is a field page.

Who are the top researchers at AstraZeneca (United Kingdom)?

Ranked on the composite score, Ian D. Wilson, David M. Smith and Teresa Klinowska lead among researchers whose main affiliation is AstraZeneca (United Kingdom).

  1. 1 Ian D. Wilson United Kingdom · #25,759 worldwide 640 citations · 58 works
  2. 2 David M. Smith United Kingdom · #62,246 worldwide 367 citations · 42 works
  3. 3 Teresa Klinowska United Kingdom · #67,778 worldwide 294 citations · 30 works
  4. 4 Richard A. Ward United Kingdom · #111,932 worldwide 396 citations · 63 works
  5. 5 Darren A.E. Cross United Kingdom · #148,827 worldwide 293 citations · 20 works
  6. 6 J. Ashby United Kingdom · #160,076 worldwide 137 citations · 26 works
  7. 7 Helen K. Angell United Kingdom · #162,509 worldwide 331 citations · 19 works
  8. 8 Ian Kimber United Kingdom · #165,056 worldwide 164 citations · 74 works
  9. 9 Helen Mann United Kingdom · #166,722 worldwide 141 citations · 24 works
  10. 10 Justin P.O. Lindemann United Kingdom · #173,945 worldwide 150 citations · 22 works
All ranked researchers at AstraZeneca (United Kingdom)

Which keywords describe research at AstraZeneca (United Kingdom)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Chemotherapy, Targeted Therapy, Diagnosis, Epidemiology, Inflammation, Medicinal Chemistry and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology62▲ 1.90×68 topics
  2. Inflammation49▲ 2.8×62 topics
  3. Chemotherapy41▲ 7.1×22 topics
  4. Clinical Trials40▲ 7.3×14 topics
  5. Diagnosis38▲ 5.0×24 topics
  6. Treatment36▲ 3.6×25 topics
  7. Cancer34▲ 3.1×39 topics
  8. Targeted Therapy33▲ 18×5 topics
  9. Management32▲ 5.0×18 topics
  10. Immunotherapy31▲ 5.2×17 topics
  11. Quality of Life31▲ 2.6×20 topics
  12. Biomarkers31▲ 5.4×14 topics
  13. Cancer Therapy30▲ 6.4×17 topics
  14. Global Burden28▲ 6.4×8 topics
  15. Medicinal Chemistry28▲ 12×11 topics
  16. Tumor Microenvironment28▲ 7.6×8 topics
  17. Genetics24▲ 4.1×12 topics
  18. Monoclonal Antibodies24▲ 32×3 topics
  19. Breast Cancer23▲ 12×9 topics
  20. Respiratory22▲ 28×2 topics
  21. Glycosylation21▲ 23×3 topics
  22. Immunology21▲ 24×2 topics
  23. Genomic Profiling21▲ 24×2 topics
  24. Asthma20▲ 25×2 topics
  25. COPD20▲ 37×1 topic
  26. spirometry20▲ 37×1 topic
  27. Pharmacokinetics20▲ 9.2×7 topics
  28. Precision Medicine19▲ 5.0×7 topics
  29. Prognostic Factors19▲ 5.3×11 topics
  30. Allergic Diseases19▲ 39×1 topic
  31. Eosinophils19▲ 39×1 topic
  32. Therapeutic Antibodies18▲ 32×2 topics
  33. Homologous Recombination18▲ 48×2 topics
  34. Treatment Guidelines17▲ 9.6×5 topics
  35. Cell Death17▲ 8.8×6 topics
  36. Resistance Mechanisms15▲ 22×2 topics
  37. Transcriptional Regulation15▲ 11×9 topics
  38. ALK Inhibitors15▲ 29×1 topic
  39. Molecular Docking15▲ 14×1 topic
  40. Virtual Screening15▲ 20×1 topic

Which research topics does AstraZeneca (United Kingdom) publish most on?

By volume in 2022–2025: Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Computational Drug Discovery Methods and Lung Cancer Treatments and Mutations.

Chronic Obstructive Pulm…20Chronic Obstructive Pulmonary Disease (COPD) Research: 20 fractional worksAsthma and respiratory d…19Asthma and respiratory diseases: 19 fractional worksComputational Drug Discovery Methods: 15 fractional worksLung Cancer Treatments a…15Lung Cancer Treatments and Mutations: 15 fractional worksMonoclonal and Polyclona…14Monoclonal and Polyclonal Antibodies Research: 14 fractional worksCancer Immunotherapy and Biomarkers: 13 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 12 fractional worksPARP inhibition in cance…12PARP inhibition in cancer therapy: 12 fractional worksCAR-T cell therapy research: 10 fractional worksHER2/EGFR in Cancer Research: 10 fractional works
Pulmonary and Respiratory MedicinePhysiologyComputational Theory and MathematicsRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 20 works
  2. 2 Asthma and respiratory diseases Physiology 19 works
  3. 3 Computational Drug Discovery Methods Computational Theory and Mathematics 15 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 15 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 14 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 13 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 12 works
  8. 8 PARP inhibition in cancer therapy Oncology 12 works
  9. 9 CAR-T cell therapy research Oncology 10 works
  10. 10 HER2/EGFR in Cancer Research Oncology 10 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.4%not open67.6%

World: 28% of research is openly available.

with international co-authors37.6%domestic only62.4%

World: 19% is written across borders.

How has AstraZeneca (United Kingdom)'s research output changed?

Output in 2018–2022 was 1% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.